IN BRIEF: Keller CEO to undergo medical treatment, will stay in role

Keller Group PLC - London-headquartered geotechnical engineering company - Chief Executive Officer Michael Speakman ‘will be undergoing necessary medical treatment’, but will continue in his role supported by Non-Executive Chair Carl-Peter Forster, the executive committee and Chief Financial Officer David Burke.

‘Michael will remain actively engaged in key strategic decisions and day-to-day leadership,’ Keller Group says. ‘The board and the entire company are fully supportive of Michael during this period.’

Current stock price: 1,558.00 pence

12-month change: up 13%

Copyright 2025 Alliance News Ltd. All Rights Reserved.